Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG Oncology NMIBC data

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Dec 02, 2022 10:09am

120 Views

Post# 35146137

RE:RE:RE:RE:CG Oncology NMIBC data

Gman620 wrote:
Less treatments, less money for big pharma. It's pretty simple. Maximizing profits = MORE treatments for longer period. What we see as a great benefit, they see as not-optimal.

True, yet we should have huge support from Insurance copanies, their lobbyists and related politicians... :-)

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec